Company News

Dengue Virus-Like particles Dengue virus serotype 3 envelope protein Dengue Virus serotype 4 NS1 Dengue Virus Serotype 2 NS1 protein Dengue Virus serotype 1 NS1 dengue NS1 protein mouse anti dengue virus NS1 serotype 1 mouse anti dengue virus NS1 serotype 2 mouse anti dengue virus NS1 serotype 3 mouse anti dengue virus NS1 serotype 4

New – Serotype specific antibodies for Dengue NS1 now available

April 23rd, 2018

We are pleased to announce the availability of a new panel of monoclonal antibodies, specific for each serotype of Dengue NS1.   These new antibodies may be used in both ELISA and WB applications, and will provide researchers the ability to distinguish between infections with the different Dengue serotypes.    

Silver-lining from zika

A silver-lining from Zika virus?

September 12th, 2017

Zika virus (ZIKV) is an enveloped single stranded RNA virus. It is a member of the Flavivirus genus of the family Flaviviridae, which is transmitted to humans primarily through the bite of the Aedes aegypti mosquito. In 2015, a major outbreak of Zika virus was associated with cases of foetal microcephaly and Guillain-Barre syndrome in […]

Mutation in Zika NS1 linked to recent epidemic

July 20th, 2017

Until recently, cases of reported Zika virus infection were very few and the disease was described as a mild self-limiting febrile illness. In 2007, however, a significant outbreak of Zika virus (ZIKV) was reported on the island of Yap and the virus has recently been responsible for major outbreaks of disease in French Polynesia in […]

Congenital CMV

Congenital CMV infection – a problem ignored?

July 5th, 2017

Congenital CMV infection – a serious problem that receives little attention Cytomegalovirus (CMV) is a human specific double stranded DNA virus, belonging to the Herpesviridae family. CMV is ubiquitous and CMV infection is globally widespread. The virus can be transmitted through direct contact with infected bodily fluids or though contact with virus infected transplant and […]

The Native Antigen Company supports R&D on emerging diseases

May 14th, 2017

The WHO Priority list of emerging diseases In 2015, a group of public health and science experts gathered in Geneva to discuss emerging pathogens, that cause human disease (1). Organised by the WHO, their aim was to prioritise infectious diseases which are likely to cause a severe epidemic and which could present a public health […]

Langford Locks services

We’re expanding to meet demand and to offer new services

April 29th, 2017

We are moving to new facilities to meet rapidly growing demand for products and services We are pleased to announce that The Native Antigen Company is moving to new, expanded bespoke facilities with effect from April 27th. 2017 These new facilities will enable us to meet the rapidly increasing demand for our products and services […]

Antibodies from The Native Antigen Company

April 19th, 2017

Antibodies are used in a wide range of research applications and immunodiagnostic assays. The reliability, reproducibility and sensitivity of an antibody is key to the success of any antibody based application and there is an increasing demand for high quality antibodies for both research and diagnostic assay development. The Native Antigen Company already has an […]

Ongoing challenges for Zika diagnostics

January 19th, 2017

Continuing challenges for Zika virus diagnostics as we move into 2017 Although the formal Public Health Emergency for Zika virus infection has been declared over, the virus continues to present major challenges to global healthcare networks. The virus continues to spread to new areas, having been reported for the first time in Texas and also […]

Zika and Usutu Virus NS1 launched

November 27th, 2015

The Native Antigen Company (NAC) announces another world first: the launch of Zika and Usutu Virus NS1 recombinant proteins expressed in our proprietary mammalian cell expression system. Zika and Usutu Virus are emerging pathogens causing increasing concern both in Brazil where a significant Zika outbreak has been occuring since 2014 and in Europe where several […]

World First: All 4 Dengue Virus NS1 Serotypes from human cell lines

September 29th, 2013

The Native Antigen Company (NAC) announces a world first: the release of all 4 Dengue Virus NS1 serotypes from human cell lines. All four DENV NS1 serotypes have been manufactured in response to the unmet need for highly purified, concentrated proteins for use in vaccine development and serological based diagnostic assays. To achieve this, the […]

Menu